Cargando…
Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma
Background. Advanced basal cell carcinoma (BCC) is often treated by surgery or X-ray therapy. The consequences of X-ray therapy on the patients' health-related quality-of-life (HRQOL) have so far not been described. Objectives. To quantify quality of life in BCC patients before and after X-ray...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539380/ https://www.ncbi.nlm.nih.gov/pubmed/23316369 http://dx.doi.org/10.1155/2012/825095 |
_version_ | 1782255076168957952 |
---|---|
author | Skiveren, Jette Mikkelsen, Maria Rudkjaer Daugbjerg, Helle Wulf, Hans Christian |
author_facet | Skiveren, Jette Mikkelsen, Maria Rudkjaer Daugbjerg, Helle Wulf, Hans Christian |
author_sort | Skiveren, Jette |
collection | PubMed |
description | Background. Advanced basal cell carcinoma (BCC) is often treated by surgery or X-ray therapy. The consequences of X-ray therapy on the patients' health-related quality-of-life (HRQOL) have so far not been described. Objectives. To quantify quality of life in BCC patients before and after X-ray therapy compared with matched healthy controls. Materials. Twenty-five patients (mean age 69) with BCC completed the Dermatology Life Quality Index (DLQI) before and two weeks and three months after X-ray therapy and their results were compared with the DLQI scores for 25 matched controls. Results. Compared to the healthy controls the patients' DLQI score was significantly higher before and 2 weeks after X-ray therapy (P = 0.005; P = 0.000). The patients' DLQI score decreased significantly from baseline to three months after X-ray therapy (P = 0.024), when it became similar to that of the healthy controls (P = 0.819). Three months after X-ray therapy eight patients had no skin reactions, 11 had slight atrophy, pigmentation change, and/or some hair loss, four had patch atrophy, moderate telangiectasia, and/or total hair loss. Conclusions. BCC has a negative effect on patients' quality of life. The study shows that HRQOL normalises shortly after X-ray therapy, despite minor skin manifestations. |
format | Online Article Text |
id | pubmed-3539380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-35393802013-01-11 Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma Skiveren, Jette Mikkelsen, Maria Rudkjaer Daugbjerg, Helle Wulf, Hans Christian J Skin Cancer Clinical Study Background. Advanced basal cell carcinoma (BCC) is often treated by surgery or X-ray therapy. The consequences of X-ray therapy on the patients' health-related quality-of-life (HRQOL) have so far not been described. Objectives. To quantify quality of life in BCC patients before and after X-ray therapy compared with matched healthy controls. Materials. Twenty-five patients (mean age 69) with BCC completed the Dermatology Life Quality Index (DLQI) before and two weeks and three months after X-ray therapy and their results were compared with the DLQI scores for 25 matched controls. Results. Compared to the healthy controls the patients' DLQI score was significantly higher before and 2 weeks after X-ray therapy (P = 0.005; P = 0.000). The patients' DLQI score decreased significantly from baseline to three months after X-ray therapy (P = 0.024), when it became similar to that of the healthy controls (P = 0.819). Three months after X-ray therapy eight patients had no skin reactions, 11 had slight atrophy, pigmentation change, and/or some hair loss, four had patch atrophy, moderate telangiectasia, and/or total hair loss. Conclusions. BCC has a negative effect on patients' quality of life. The study shows that HRQOL normalises shortly after X-ray therapy, despite minor skin manifestations. Hindawi Publishing Corporation 2012 2012-12-20 /pmc/articles/PMC3539380/ /pubmed/23316369 http://dx.doi.org/10.1155/2012/825095 Text en Copyright © 2012 Jette Skiveren et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Skiveren, Jette Mikkelsen, Maria Rudkjaer Daugbjerg, Helle Wulf, Hans Christian Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma |
title | Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma |
title_full | Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma |
title_fullStr | Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma |
title_full_unstemmed | Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma |
title_short | Skin Reactions and Quality of Life after X-Ray Therapy of Basal Cell Carcinoma |
title_sort | skin reactions and quality of life after x-ray therapy of basal cell carcinoma |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539380/ https://www.ncbi.nlm.nih.gov/pubmed/23316369 http://dx.doi.org/10.1155/2012/825095 |
work_keys_str_mv | AT skiverenjette skinreactionsandqualityoflifeafterxraytherapyofbasalcellcarcinoma AT mikkelsenmariarudkjaer skinreactionsandqualityoflifeafterxraytherapyofbasalcellcarcinoma AT daugbjerghelle skinreactionsandqualityoflifeafterxraytherapyofbasalcellcarcinoma AT wulfhanschristian skinreactionsandqualityoflifeafterxraytherapyofbasalcellcarcinoma |